Discussing the Potential of Novel Agents for Treatment of GIST
November 18th 2019Winston Tan, MD, discusses the emergence of novel agents for the treatment of patients with gastrointestinal stromal tumors, namely agents like avapritinib and ripretinib, which have shown promise in ongoing clinical trials.<br />
Watch